Bioinformatic prediction of putative conveyers of O-GlcNAc transferase intellectual disability

被引:5
作者
Mitchell, Conor W. [1 ,2 ]
Czajewski, Ignacy [2 ]
Aalten, Daan M. F. van [1 ,2 ]
机构
[1] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark
[2] Univ Dundee, Sch Life Sci, Div Cell & Dev Biol, Dundee, Scotland
基金
英国惠康基金;
关键词
ELECTRON-TRANSFER DISSOCIATION; MODIFIED PROTEINS; DNA-BINDING; SUBCELLULAR-DISTRIBUTION; GLOBAL IDENTIFICATION; MASS-SPECTROMETRY; STRUCTURAL BASIS; BETA-TUBULIN; ACTIVE-SITE; GLCNACYLATION;
D O I
10.1016/j.jbc.2022.102276
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein O-GlcNAcylation is a dynamic posttranslational modification that is catalyzed by the enzyme O-GlcNAc transferase (OGT) and is essential for neurodevelopment and postnatal neuronal function. Missense mutations in OGT segregate with a novel X-linked intellectual disability syn-drome, the OGT congenital disorder of glycosylation (OGT-CDG). One hypothesis for the etiology of OGT-CDG is that loss of OGT activity leads to hypo-O-GlcNAcylation of as yet un-identified, specific neuronal proteins, affecting essential em-bryonic, and postnatal neurodevelopmental processes; however, the identity of these O-GlcNAcylated proteins is not known. Here, we used bioinformatic techniques to integrate sequence conservation, structural data, clinical data, and the available literature to identify 22 candidate proteins that convey OGT-CDG. We found using gene ontology and PANTHER database data that these candidate proteins are involved in diverse processes including Ras/MAPK signaling, translational repression, cytoskeletal dynamics, and chromatin remodeling. We also identify pathogenic missense variants at O-GlcNAcylation sites that segregate with intellectual disability. This work establishes a preliminary platform for the mechanistic dissection of the links between protein O-GlcNAcylation and neurodevelopment in OGT-CDG.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Metabolic Inhibitors of O-GlcNAc Transferase That Act In Vivo Implicate Decreased O-GlcNAc Levels in Leptin-Mediated Nutrient Sensing
    Liu, Tai-Wei
    Zandberg, Wesley F.
    Gloster, Tracey M.
    Deng, Lehua
    Murray, Kelsey D.
    Shan, Xiaoyang
    Vocadlo, David J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (26) : 7644 - 7648
  • [32] Multi-omics after O-GlcNAc alteration identified cellular processes promoting aneuploidy after loss of O-GlcNAc transferase
    Boyd, Samuel S.
    Robarts, Dakota R.
    Nguyen, Khue
    Villar, Maite
    Alghusen, Ibtihal M.
    Kotulkar, Manasi
    Denson, Aspin
    Fedosyuk, Halyna
    Whelan, Stephen A.
    Lee, Norman C. Y.
    Hanover, John
    Dias, Wagner B.
    Tan, Ee Phie
    McGreal, Steven R.
    Artigues, Antonio
    Swerdlow, Russell H.
    Thompson, Jeffrey A.
    Apte, Udayan
    Slawson, Chad
    MOLECULAR METABOLISM, 2024, 90
  • [33] Exploration of O-GlcNAc transferase glycosylation sites reveals a target sequence compositional bias
    Chong, P. Andrew
    Nosella, Michael L.
    Vanama, Manasvi
    Ruiz-Arduengo, Roxana
    Forman-Kay, Julie D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (05)
  • [34] O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension
    Barnes, Jarrod W.
    Tian, Liping
    Krick, Stefanie
    Helton, E. Scott
    Denson, Rebecca S.
    Comhair, Suzy A. A.
    Dweik, Raed A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [35] Design of glycosyltransferase inhibitors targeting human O-GlcNAc transferase (OGT)
    Wang, Shuai
    Shen, David L.
    Lafont, Dominique
    Vercoutter-Edouart, Anne-Sophie
    Mortuaire, Marlene
    Shi, Yun
    Maniti, Ofelia
    Girard-Egrot, Agnes
    Lefebyre, Tony
    Pinto, B. Mario
    Vocadlo, David
    Vidal, Sebastien
    MEDCHEMCOMM, 2014, 5 (08) : 1172 - 1178
  • [36] Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
    Xia, Mingyue
    Wang, Shuyan
    Qi, Yannan
    Long, Kaili
    Li, Enjie
    He, Lingfeng
    Pan, Feiyan
    Guo, Zhigang
    Hu, Zhigang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Structure of human O-GlcNAc transferase and its complex with a peptide substrate
    Lazarus, Michael B.
    Nam, Yunsun
    Jiang, Jiaoyang
    Sliz, Piotr
    Walker, Suzanne
    NATURE, 2011, 469 (7331) : 564 - U168
  • [38] Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase
    Levine, Zebulon G.
    Potter, Sarah C.
    Joiner, Cassandra M.
    Fei, George Q.
    Nabet, Behnam
    Sonnett, Matthew
    Zachara, Natasha E.
    Gray, Nathanael S.
    Paulo, Joao A.
    Walker, Suzanne
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (04)
  • [39] O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
    Barkovskaya, Anna
    Seip, Kotryna
    Hilmarsdottir, Bylgja
    Maelandsmo, Gunhild M.
    Moestue, Siver A.
    Itkonen, Harri M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Upregulation of O-GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia
    He, Na
    Ma, Daoxin
    Tan, Yanjie
    Liu, Min
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E318 - E328